Aliquots
-
New player in neuronal communication
Vanderbilt researchers have discovered a novel mechanism for the development of dendritic spines – sites of nerve cell communication. Read MoreMay 1, 2015
-
RNA defects in multiple sclerosis
Vanderbilt researchers have discovered that profound defects exist in the integrity of structural RNA molecules in patients with relapsing remitting multiple sclerosis. Read MoreApr 30, 2015
-
Best hospital depends on cancer type
Best hospital rankings for cancer do not take into account the fact that cancer reflects many different diseases. Read MoreApr 22, 2015
-
Boosting beta cells in diabetes
New findings suggest that it might be possible to treat diabetes by regenerating insulin-producing beta cells in the pancreas. Read MoreApr 20, 2015
-
Stuffed animals bring bacteria to OR
Stuffed animals that pediatric patients bring to the operating room are a reservoir of bacteria that can be effectively sterilized in a household washer/dryer the day before surgery. Read MoreApr 17, 2015
-
Surprising finding in the kidney
TGF-beta signaling in the kidney was thought to be a target for reducing renal fibrosis, but Vanderbilt researchers report that fibrosis still occurs in the absence of TGF-beta signaling. Read MoreApr 16, 2015
-
Micelle “packets” deliver cancer drugs
Vanderbilt researchers designed micelle “packets” to selectively deliver anti-cancer drugs to breast cancer cells. Read MoreApr 8, 2015
-
New player in heart cell growth
Vanderbilt researchers have identified a new protein involved in heart cell growth, which could improve understanding of pathologic cardiac hypertrophy. Read MoreApr 6, 2015
-
Cancer signaling pathway blocker
Researchers at Vanderbilt University have discovered a new way to inhibit Hedgehog (Hh) signaling, an important regulatory pathway for vertebrate development – and cancer. Read MoreApr 3, 2015
-
Aging insights from budding yeast
The proteins that control entry and exit from the cell nucleus influence aging, Vanderbilt researchers have discovered. Read MoreApr 2, 2015
-
New systems biology method may help improve vaccine evaluation
Researchers at Vanderbilt University have found a new way to “dissect” the human immune response following influenza vaccination. Read MoreMar 23, 2015
-
Streptococcus virulence involves three-step plasminogen binding
Researchers at Vanderbilt have shown for the first time how a component of streptococci A and C bacteria helps spread the virus so rapidly through the body. Read MoreMar 20, 2015
-
Multi-sensory processing model explores autism, schizophrenia
There is growing evidence that disorders such as autism and schizophrenia involve deficits in what is called “multi-sensory processing,” the ability of the brain to properly integrate information coming in through the eyes, ears and other senses. Read MoreMar 19, 2015
-
Antibiotics with anticancer potential
A series of experimental antibiotics may be a good starting point for developing new anticancer drugs. Read MoreFeb 25, 2015
-
Contributors to coronavirus ‘fitness’
Understanding the role that host membrane modification plays in coronavirus replication is essential for developing novel approaches to block the viruses that cause SARS and MERS. Read MoreFeb 24, 2015
-
Tiny model of diabetes
Vanderbilt University researchers have created a zebrafish model of skeletal muscle insulin resistance that could help improve diabetes treatment. Read MoreFeb 20, 2015
-
‘Stretched’ cells promote cancer
Mechanical stress appears to be a critical factor in activating normal tissue-associated fibroblasts to generate cancer-associated fibroblasts. Read MoreFeb 19, 2015
-
Kidney disease impacts HDL function
Chronic kidney disease impairs the protective functions of HDL, Vanderbilt researchers report this month. Read MoreFeb 11, 2015
-
Targeting HIV’s “cap”
New findings underscore the attractiveness of the HIV capsid – the structure that encloses the viral genome – as a therapeutic target. Read MoreFeb 10, 2015
-
Gene profile predicts metastasis
A specific gene expression profile represents a novel, biologically relevant “signature” for identifying colon cancers with high risk of metastatic recurrence, Vanderbilt researchers have found. Read MoreFeb 9, 2015